EmpowerCTA®+

Injector System

Helping your business grow by delivering quality diagnostics that boost productivity, promote safety, and reduce overhead

Explore unique designs and features to advance diagnostic capabilities

Savings

Reduce capital spending with innovative technology

Safety

Promote safety and support patient-centric care

Efficiency

Maximize efficiencies with improved interoperability

Imaging

Enhance imaging and simplify procedures with unique protocols

Reduce capital burden with state-of-the-art Bracco injectors

Bracco helped a top imaging group eliminate $1.8 million1 in capital spend while upgrading their entire CT injector fleet to the latest technology.

Learn More

Unique protocols designed to lower contrast spend

Economic analysis project cost savings with dual-syringe-protocoling across several scenarios such as utilizing unique saline-based protocols to2-6:

 

  • Enhance study quality
  • Eliminate excess contrast
  • Support patient hydration

Impact of Protocols on Hospital Budgets7

EmpowerCTA+ Injector System

Simplify your workday

Custom safety features designed to promote patient-centric care

Saline Advance

Saline Jump

Tilt Sensor Lock CT

Pendant Switch 

Variable Flow Rates 

Evaluate Kidney Function

Innovative designs to maximize efficiency and streamline workflow

Auto initialization

Auto initialization helps you efficiently prepare syringes.

Protocol fill

Protocol fill automatically fills syringes to specified volumes.

Prime for injection with purge to line

This feature easily purges the saline and contrast, so the injector is ready for use.

Innovative designs to maximize efficiency and streamline workflow

Auto initialization

Auto initialization helps you efficiently prepare syringes.

Protocol fill

Protocol fill automatically fills syringes to specified volumes.

Prime for injection with purge to line

This feature easily purges the saline and contrast, so the injector is ready for use.

Enhance diagnostic imaging

Maximize the quality of a cardiac CT study with EPP™

The combination of Empower Phasing Protocol (EPPTM) and the injector system allows dual syringes to alternate between contrast and a saline chase to help maximize the quality of a cardiac CT study.

A. Courtesy of Suhny Abbara, MD, Assistant Professor, Harvard Medical School, Director, Cardiovascular Imaging, Massachusetts General Hospital, Director of Education, Cardiac MR/PET /CT Program
B, C. Courtesy of Orla Buckley, MD, Andetta Hunsaker, MD, and Frank Rybicki, MD, Brigham and Women’s Hospital, Applied Imaging Science Laboratory, Department of Radiology

EmpowerSync® simplifies CT imaging

EmpowerSync® allows for interoperability between contrast delivery systems and CT scanners.*

 

EmpowerSync is a registered trademark of Bracco Injeneering S.A.; EPP is a trademark of ACIST Medical Systems. Inc.
*Please work with your local specialist for compatibility with your specific scanner.
Point-of-care MR imaging solutions that help promote patient safety and streamline workflow
Discover More
Enterprise-wide digital solutions connecting you to data when and where you need it
Learn More
Explore insights about improving efficiency and optimizing care
Explore More

IMPORTANT SAFETY INFORMATION | INDICATIONS AND USAGE

EmpowerCTA®+ Injector System
Caution: Federal law restricts this device to sale by or on the order of a physician.
INDICATIONS:
The EmpowerCTA®+ Injector System is indicated for the vascular administration of contrast and flushing media in conjunction with computed tomography (CT) scanning of the body with an optional interface to a CT scanner and an optional calculator for glomerular filtration rate (GFR).

INDICATIONS AND USAGE | IMPORTANT SAFETY INFORMATION

EmpowerCTA®+ Injector System

 

Caution: Federal law restricts this device to sale by or on the order of a physician.

 

INDICATIONS:

The EmpowerCTA®+ Injector System is indicated for the vascular administration of contrast and flushing media in conjunction with computed tomography (CT) scanning of the body with an optional interface to a CT scanner and an optional calculator for glomerular filtration rate (GFR).

 

Protocols have been independently developed and are not intended as medical advice. Bracco and Bracco Injeneering S.A. shall not be responsible for any physicians’ reliance on these or any other products.

 

CONTRAINDICATIONS:

 

The EmpowerCTA®+ Injector System is not intended for use as a long-term infusion pump, nor is it intended to be used to inject any agents other than contrast or flushing media. Do not attempt to use the injector for any other purpose (such as chemotherapy or drug infusion). The EmpowerCTA+ Injector System should not be used to inject substances into nonvascular body cavities. Any applications of the EmpowerCTA+ Injector System other than those described in its Operator Manual are inappropriate and should not be attempted.

 

Not all products are available in all global markets.

 

EmpowerCTA+ is distributed by Bracco Diagnostics Inc.; 510 Carnegie Center Drive, Suite 300, Princeton, NJ 08540 USA; Phone: (800) 631-5245; Fax: (609) 514-2424; Customer Service: 1-877-BRACCO 9 (1-877-272-2269); Scientific Information: 1-800-257-5181 (Option 2); EmpowerCTA+ Email: empowerinfo@diag.bracco.com; Website: https://smartinject.com/ct-solutions/

 

EmpowerCTA+ is manufactured by Bracco Injeneering S.A., Avenue de Sevelin 46, CH – 1004 Lausanne, Switzerland. https://www.bracco.com/

 

EmpowerMR® Injector System

 

Caution: Federal law restricts this device to sale by or on the order of a physician.

 

INDICATIONS:

 

The EmpowerMR® Injector System is indicated for vascular administration of contrast media and flushing media in conjunction with magnetic resonance imaging (MRI).

 

Protocols have been independently developed and are not intended as medical advice, and Bracco shall not be responsible for any physicians' reliance on these or any other protocols.

 

Bracco Injeneering S.A. reserves the right at any time and without notice, to change the specifications and features described herein, or to change the production or adjust the product described.

 

Not all products are available in all global markets.

 

EmpowerMR is distributed by Bracco Diagnostics Inc.; 510 Carnegie Center Drive, Suite 300, Princeton, NJ 08540 USA; Phone: (800) 631-5245; Fax: (609) 514-2424; Customer Service: 1-877-BRACCO 9 (1-877-272-2269); Scientific Information: 1-800-257-5181 (Option 2); Website: https://smartinject.com/mr-solutions/

 

EmpowerMR is manufactured for Bracco Injeneering S.A., Avenue de Sevelin 46 CH – 1004 Lausanne, Switzerland. https://www.bracco.com/

 

NEXO® Contrast Management System

 

Intended Use:

 

The NEXO® Contrast Management System is a server-based application intended to be used as a data management and visualization system. The NEXO Contrast Management System can read, store, share, compare/relate, as well as graphically display data and injection programs coming from RIS, PACS, and multiple enabled EmpowerCTA® Injector Systems. This device provides users with record lists, graphics, and reports about data and performances.

 

This device is intended for retrospective and statistical data management and visualization. It is not intended for real-time data visualization, diagnostic applications, or for any other use for which the device is not indicated. This device is only to be operated by and under quasi-continuous supervision of qualified and trained staff in an appropriately licensed healthcare facility.

 

The NEXO Contrast Management System is compatible with the EmpowerCTA Injector System version 8.0, and EmpowerCTA®+ Injector System version 10.0 and higher.

 

Not all products are available in all global markets.

 

NEXO is distributed by Bracco Diagnostics Inc.; 510 Carnegie Center Drive, Suite 300, Princeton, NJ 08540 USA; Phone: (800) 631-5245; Fax: (609) 514-2424; NEXO Customer Service: 1-877-BRACCO 9 (1-877-272-2269); NEXO questions: Nexo.Answers@diag.bracco.com; NEXO U.S. Technical Service and Support: Phone: 888-670-7701; Fax: 609-514-2448; NEXO Email: customer.support@acistmedical.com; Website: https://smartinject.com/digital-solutions

 

NEXO is manufactured by ACIST Medical Systems, 7905 Full Road, Eden Prairie, MN 55344 USA.

 

About Bracco Injeneering S.A.

Bracco Injeneering S.A., located in Lausanne, Switzerland, is the most recently added Business Unit of Bracco Imaging. Bracco Injeneering is committed to developing the best-in-class, integrated injection solutions with a strong heritage in research and innovation. It provides quality solutions for state-of-the-art radiology centers, offering proven injection technology, built on Bracco Imaging’s expertise.

 

Thanks to this strengthened product portfolio, including the EmpowerCTA®+ Injector System and EmpowerMR Injector System Bracco Imaging will be able to focus on constant innovation, not only for devices but also for software development and data management.

 

EmpowerCTA, EmpowerMR, NEXO, and IRiSMR are registered trademarks of ACIST Medical Systems, Inc.

 

FastLoad is a trademark of ACIST Medical Systems, Inc.

 

ulricheasyINJECT Max 3™

ulricheasyINJECT Max 3 is manufactured by ulrich GmbH & Co. KG.

ulrich medical is a registered trademark of ulrich GmbH & Co. KG.

ulricheasyINJECT Max 3 is a trademark of ulrich GmbH & Co. KG.

ulricheasyINJECT Max 3 is distributed by Bracco Diagnostics Inc.; 510 Carnegie Center Drive,
Suite 300; Princeton, NJ 08540 USA; Phone: (800) 631-5245; Fax: (609) 514-2424;
Customer Service: 1-877-BRACCO 9 (1-877-272-2269); Scientific Information: 1-800-257-5181
(Option 2); Website: https://smartinject.com

 

All other trademarks and registered trademarks are the property of their respective owners.

References:

1. Data on file. Bracco Diagnostics Inc. July 2020.
2. Auler MA, Heagy T, Aganovic I, et al. Saline chasing technique with dual-syringe injection systems for multi-detector row computed tomographic angiography: rationale, indications, and protocols. Current Problems Diagnostic Radiology. 2006;35(2):1-11.
3. Bae KT. Optimization of contrast enhancement in thoracic MDCT. Radiol Clin North Am. 2010;48(1):9-29.
4. Cademartiri F, van der Lugt A, Luccichenti G, et al. Parameters affecting bolus geometry in CTA: a review. J Comput Assist Tomogr. 2002;26(4):598-607.
5. Cademartiri F, Mollet N, van der Lugt A, et al. Non-invasive 16-row multislice CT coronary angiography: usefulness of saline chaser. Eur Radiol. 2004;14(2):178-183.
6. Thompson L. Flushing the line between medications in IV administration of multiple agents. Oncology Nurse Advisor website. https://www.oncologynurseadvisor.com/oncology-nursing/flushing-the-iv-line-between-medications/article/509061/. Updated July 12, 2016. Accessed April 17, 2018.
7. Data on file. “Auto injector.” Bracco Diagnostics Inc. July 2020.

IMPORTANT SAFETY INFORMATION | INDICATIONS AND USAGE
EmpowerCTA®+ Injector System
Caution: Federal law restricts this device to sale by or on the order of a physician.
INDICATIONS:
The EmpowerCTA®+ Injector System is indicated for the vascular administration of contrast and flushing media in conjunction with computed tomography (CT) scanning of the body with an optional interface to a CT scanner and an optional calculator for glomerular filtration rate (GFR).

Reduce extravasations and test patency and vein integrity with Saline Advance

"Saline Advance is helpful; my technologists find it helpful to test the IVs beforehand to see, can it handle this pressure without an extravasation ... the tech can go ahead and use the saline advance in order to determine if it will work for the whole contrast injection. If it can't handle that pressure with advance, then they need different access."

—Stanley Weinstein, MD
Poudre Valley Hospital

Reduce extravasations and test patency and vein integrity with Saline Advance

"Saline Advance is helpful; my technologists find it helpful to test the IVs beforehand to see, can it handle this pressure without an extravasation ... the tech can go ahead and use the saline advance in order to determine if it will work for the whole contrast injection. If it can't handle that pressure with advance, then they need different access."

—Stanley Weinstein, MD
Poudre Valley Hospital

Eliminate excess contrast with Saline Jump

"[Saline Jump] Especially with pulmonary embolism studies, the ability to shut down the contrast injection and be able to push saline if the scan is already completed and you have opacification, there is no reason to inject the full bolus, that will reduce the amount of contrast a patient gets, and theoretically reduce the risk of contrast-induced nephropathy, as well as potentially reduce the amount of contrast injected before we start the exam."

-Stanley Weinstein, MD
Poudre Valley Hospital

Eliminate excess contrast with Saline Jump

"[Saline Jump] Especially with pulmonary embolism studies, the ability to shut down the contrast injection and be able to push saline if the scan is already completed and you have opacification, there is no reason to inject the full bolus, that will reduce the amount of contrast a patient gets, and theoretically reduce the risk of contrast-induced nephropathy, as well as potentially reduce the amount of contrast injected before we start the exam."

-Stanley Weinstein, MD
Poudre Valley Hospital

Reduce air embolism risk

Tilt sensor and lock reduces risk of air embolisms by monitoring the injector head position to safely deliver contrast

Reduce air embolism risk

Tilt sensor and lock reduces risk of air embolisms by monitoring the injector head position to safely deliver contrast

Pendant switch allows you to start, stop, and pause injections right by the patient's side

Pendant switch allows you to start, stop, and pause injections right by the patient's side

Variable flow rates let you adjust contrast and saline flow as needed during injection.

Variable flow rates let you adjust contrast and saline flow as needed during injection.

Evaluate Kidney Function

The eGFR calculator is intended to assist the facility in determining whether the patient's renal function is consistent with the safe administration of intravenous (IV) contrast.

 

eGFR=estimated glomerular filtration rate.
eGFR is not intended to act as a substitute for a physician's diagnosis of conditions, which may preclude the administration of IV contrast or the patient’s ability to accept the procedure.

Evaluate Kidney Function

The eGFR calculator is intended to assist the facility in determining whether the patient's renal function is consistent with the safe administration of intravenous (IV) contrast.

 

eGFR=estimated glomerular filtration rate.
eGFR is not intended to act as a substitute for a physician's diagnosis of conditions, which may preclude the administration of IV contrast or the patient’s ability to accept the procedure.